69 related articles for article (PubMed ID: 17029043)
1. Infliximab acts directly on human osteoclast precursors and enhances osteoclast formation induced by receptor activator of nuclear factor kappaB ligand in vitro.
Takita C; Fujikawa Y; Itonaga I; Taira H; Kawashima M; Torisu T
Mod Rheumatol; 2005; 15(2):97-103. PubMed ID: 17029043
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.
Miyazaki M; Fujikawa Y; Takita C; Tsumura H
Clin Rheumatol; 2007 Feb; 26(2):231-9. PubMed ID: 16586042
[TBL] [Abstract][Full Text] [Related]
3. Synovial fluid macrophages are capable of osteoclast formation and resorption.
Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
[TBL] [Abstract][Full Text] [Related]
4. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
Sabokbar A; Kudo O; Athanasou NA
J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
[TBL] [Abstract][Full Text] [Related]
5. Synovial macrophage-osteoclast differentiation in inflammatory arthritis.
Danks L; Sabokbar A; Gundle R; Athanasou NA
Ann Rheum Dis; 2002 Oct; 61(10):916-21. PubMed ID: 12228163
[TBL] [Abstract][Full Text] [Related]
6. The effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitro.
Kawashima M; Fujikawa Y; Itonaga I; Takita C; Tsumura H
Mod Rheumatol; 2009; 19(2):192-8. PubMed ID: 19198759
[TBL] [Abstract][Full Text] [Related]
7. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
Adamopoulos IE; Wordsworth PB; Edwards JR; Ferguson DJ; Athanasou NA
Hum Pathol; 2006 Sep; 37(9):1176-85. PubMed ID: 16938523
[TBL] [Abstract][Full Text] [Related]
8. Menatetrenone (vitamin K2) acts directly on circulating human osteoclast precursors.
Taira H; Fujikawa Y; Kudo O; Itonaga I; Torisu T
Calcif Tissue Int; 2003 Jul; 73(1):78-85. PubMed ID: 14506958
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus capsular material promotes osteoclast formation.
Lau YS; Wang W; Sabokbar A; Simpson H; Nair S; Henderson B; Berendt A; Athanasou NA
Injury; 2006 May; 37 Suppl 2():S41-8. PubMed ID: 16651071
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts.
Azuma Y; Kaji K; Katogi R; Takeshita S; Kudo A
J Biol Chem; 2000 Feb; 275(7):4858-64. PubMed ID: 10671521
[TBL] [Abstract][Full Text] [Related]
11. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM; Nishioka K; Yudoh K
Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
[TBL] [Abstract][Full Text] [Related]
12. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of osteoclast formation by inflammatory synovial fluid.
Adamopoulos IE; Danks L; Itonaga I; Locklin RM; Sabokbar A; Ferguson DJ; Athanasou NA
Virchows Arch; 2006 Jul; 449(1):69-77. PubMed ID: 16642388
[TBL] [Abstract][Full Text] [Related]
14. Role of LIGHT in the pathogenesis of joint destruction in rheumatoid arthritis.
Sabokbar A; Afrough S; Mahoney DJ; Uchihara Y; Swales C; Athanasou NA
World J Exp Med; 2017 May; 7(2):49-57. PubMed ID: 28589079
[TBL] [Abstract][Full Text] [Related]
15. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro.
Yamaguchi M; Uchiyama S
Int J Mol Med; 2004 Jul; 14(1):81-5. PubMed ID: 15202020
[TBL] [Abstract][Full Text] [Related]
16. Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening.
Sabokbar A; Itonaga I; Sun SG; Kudo O; Athanasou NA
J Orthop Res; 2005 May; 23(3):511-9. PubMed ID: 15885469
[TBL] [Abstract][Full Text] [Related]
17. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
Edwards JR; Sun SG; Locklin R; Shipman CM; Adamopoulos IE; Athanasou NA; Sabokbar A
Arthritis Rheum; 2006 May; 54(5):1451-62. PubMed ID: 16649193
[TBL] [Abstract][Full Text] [Related]
18. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
Gravallese EM; Manning C; Tsay A; Naito A; Pan C; Amento E; Goldring SR
Arthritis Rheum; 2000 Feb; 43(2):250-8. PubMed ID: 10693863
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation.
Kudo O; Fujikawa Y; Itonaga I; Sabokbar A; Torisu T; Athanasou NA
J Pathol; 2002 Oct; 198(2):220-7. PubMed ID: 12237882
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
